-transparent.png){kind=logo}
The efficacy of class 1C antiarrhythmic agents was determined in 36 patients with inducible sustained monomorphic ventricular tachycardia during baseline electrophysiology study (EPS), who continued to have inducible monomorphic ventricular tachycardia during EPS on class 1A antiarrhythmic therapy. Of 12 patients who partially responded to class 1A drugs, 11 (91.7%) continued to have a partial response during EPS on class 1C therapy, whereas one patient did not respond. Of 24 nonresponders to class 1A therapy, 2 (8.3%) responded during EPS on class 1C therapy, 7 (29.2%) partially responded, and 15 (62.5%) did not respond. In the 24 nonresponders to class 1A therapy, 9 of 17 patients (53%) with left ventricular ejection fraction (EF) > or = 30% responded or partially responded to class 1C therapy, compared with none of 7 patients with EF < 30% (P < .05). The EPS on class 1C agents in patients who fail to respond to class 1A therapy may be warranted only in those with EF > or = 30%.
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
September 1992,
American heart journal,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
November 1995,
European heart journal,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
March 1981,
Circulation,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
July 1992,
Circulation,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
July 1986,
American heart journal,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
January 2002,
Klinicheskaia meditsina,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
May 1988,
The American journal of cardiology,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
September 1983,
American heart journal,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
July 1991,
Circulation,
J E Tisdale, and
J Kluger, and
J R Fisher, and
M S Chow
January 1987,
Journal of the American College of Cardiology,
